Biotechnology News

SANDWICH, United Kingdom, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today...

Munich, Germany, Jan. 20, 2026 (GLOBE NEWSWIRE) -- smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the in-licensing of a new...

La Société retire volontairement ses demandes d’autorisation de mise sur le marché (BLA) et d’essais cliniques (IND) aux États-Unis Et continue d’évaluer le potentiel mondial du produit en fonction...

Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and commercial attractiveness Saint Herblain (France), January...

KUALA LUMPUR, Malaysia, Jan. 19, 2026 (GLOBE NEWSWIRE) -- CUKTECH telah mengumumkan pelancaran rasmi produk andalannya, Stesen Pengecasan CUKTECH 30 Ultra, yang akan tiba di Malaysia pada pukul 8:00...

KUALA LUMPUR, Malaysia, Jan. 19, 2026 (GLOBE NEWSWIRE) -- CUKTECH has officially announced the launch of its flagship product, the CUKTECH 30 Ultra Charging Station, arriving in Malaysia at 8:00 PM...

CHAPEL-EN-LE-FRITH, United Kingdom, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Concept Life Sciences, a leading global contract research organization (CRO) specialising in integrated drug discovery,...

KØBENHAVN, Danmark, 19. januar 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggør transaktioner under aktietilbagekøbsprogrammet, der blev iværksat den 7. januar 2026, hvorunder selskaber vil...

COPENHAGEN, Denmark, January 19, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on January 7, 2026, under which the Company will repurchase...

EMERYVILLE, Calif., Jan. 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted...